Michaela Fontenay
6Patents
1h-index
11Co-inventors
44Inventor score
Filing activity: Jun 12, 2009 → Apr 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9389233B2 | TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms | Chemistry; Metallurgy | 2 | Active |
| US10662482B2 | TET2 as a diagnostic and prognostic marker in hematopoietic neoplasms | Chemistry; Metallurgy | 1 | Active |
| US9675590B2 | Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes | Human Necessities | 0 | Active |
| US9297046B2 | TET2 as a new diagnostic and pronostic marker in hematopoietic neoplasms | Chemistry; Metallurgy | 0 | Active |
| US9540431B2 | Inhibitors of the CD95 signaling pathway for treatment of MDS | Physics | 0 | Active |
| US11203788B2 | TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.